• Avik Arakelyan

    Avetik Arakelyan

    Advisor

    Avetik Arakelyan

    • Investment professional with primary focus on healthcare venture capital
    • Experienced in VC investments focusing on drug development, fine chemistry and industrial technologies
    • Previously worked in M&A at KPMG and in business valuation at PwC
    • CFA charterholder
    Go To LinkedIn
  • Sourav Sinha

    Sourav Sinha

    Associate Partner, Head of Strategy

    Sourav Sinha

    • Founder, CEO of Oncolinx
    • Strategy at Celularity
    • Forbes’ “30 Under 30: Healthcare”
    • World Economic Forum Global Shaper
    • Singularity University Global Solutions Program
    • Dartmouth College
    Go To LinkedIn
  • Kris Verburgh, MD

    Kris Verburgh, MD

    Venture Partner

    Kris Verburgh, MD

    • Medical doctor, specializing in health, aging and the future of medicine and biotechnology
    • Researcher at Free University of Brussels
    • Faculty member Singularity University Benelux (Medicine and Longevity)
    • Creator of nutrigerontology, a new scientific discipline studying the impact of nutrition on the aging process and age-related diseases
    • Author of “The Longevity Code”
    Go To LinkedIn
  • Dmitry Vorontsov

    Dmitry Vorontsov

    Director, Finance & Investments

    Dmitry Vorontsov

    • Finance professional with 15+ years’ experience in all aspects of corporate finance and accounting
    • Has work experience at large US financial and investment companies – Dynasty Financial Partners, Jamison Capital and The Carlyle Group hedge funds, as well as Barclays and Renaissance Capital investment banks
    • Master’s degree in Accounting, Financial Analysis and Audit
    Go To LinkedIn
  • Tim Safin

    Tim Safin

    Associate

    Tim Safin

    • Investment professional with a primary focus on biotechnology venture capital
    • Experienced in VC and public companies investments focusing on the development of breakthrough therapies
    • Previously worked in Strategy Consulting (IQVIA and KPMG) supporting Big Pharma and Biotechnology companies in organic business growth, M&A and transformation
    Go To LinkedIn
  • Gunner Hardy

    Gunner Hardy

    Analyst

    Gunner Hardy

    • Investment professional with a primary focus on biotechnology venture capital
    • Experienced in banking and private company investments covering origination, structuring, execution, and implementation
    • Previously worked in Banking (BAML, EBRD and World Bank) and Life Sciences Research (Skoltech)
    • Master’s degrees in Life Sciences (Biotechnology) and Finance
    Go To LinkedIn
  • Sun Altbach

    Sun Altbach

    Senior Scientific Advisor

    Sun Altbach

    • Biopharmaceutical executive and entrepreneur with 20 years of experience
    • Have advanced innovative therapies through key inflection points for private, early-stage companies as well as some of the industry’s preeminent publicly listed global firms
    • Previously worked at Biogen, Sanofi Genzyme, Shire Pharmaceuticals
    • Founding CEO of PIC Therapeutics, cancer therapeutics company
    • Advisory Board Member at The Termeer Foundation
    • Member of Women In Bio association
    Go To LinkedIn